The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction
Journal article
Willemsen, Suzan, Hartog, Jasper, van Veldhuisen, Dirk, van der Meer, Peter, Roze, Joline, Jaarsma, Tiny, Schalkwijk, Casper, van der Horst, Iwan, Hillege, Hans and Voors, Adriaan. (2012). The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction. American Heart Journal. 164(5), pp. 742 - 749. https://doi.org/10.1016/j.ahj.2012.07.027
Authors | Willemsen, Suzan, Hartog, Jasper, van Veldhuisen, Dirk, van der Meer, Peter, Roze, Joline, Jaarsma, Tiny, Schalkwijk, Casper, van der Horst, Iwan, Hillege, Hans and Voors, Adriaan |
---|---|
Abstract | Introduction: Advanced glycation end products (AGEs) are increased in patients with heart failure (HF). We studied the predictive value of plasma AGEs Nε-(carboxymethyl)lysine (CML), pentosidine, and the soluble form of its receptor (sRAGE) in a large HF population. |
Year | 2012 |
Journal | American Heart Journal |
Journal citation | 164 (5), pp. 742 - 749 |
ISSN | 0002-8703 |
Digital Object Identifier (DOI) | https://doi.org/10.1016/j.ahj.2012.07.027 |
Page range | 742 - 749 |
Research Group | Mary MacKillop Institute for Health Research |
Publisher's version | File Access Level Controlled |
Permalink -
https://acuresearchbank.acu.edu.au/item/86486/the-role-of-advanced-glycation-end-products-and-their-receptor-on-outcome-in-heart-failure-patients-with-preserved-and-reduced-ejection-fraction
Restricted files
Publisher's version
(1 files)
108
total views0
total downloads5
views this month0
downloads this month